The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 | Zendy

Arturo Casadevall | Zendy; Liiseanne Pirofski | Zendy; Michael J. Joyner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19

Author(s) -

Arturo Casadevall,

Liiseanne Pirofski,

Michael J. Joyner

Publication year - 2021

Publication title -

mbio

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.562

H-Index - 121

eISSN - 2161-2129

pISSN - 2150-7511

DOI - 10.1128/mbio.03372-20

Subject(s) - covid-19 , virology , relevance (law) , antibody therapy , medicine , antibody , pandemic , betacoronavirus , immunology , coronavirus infections , sars virus , infectious disease (medical specialty) , disease , outbreak , monoclonal antibody , pathology , political science , law

Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins differ from conventional antimicrobial agents in that they mediate direct and indirect antimicrobial effects that work in concert with other components of the immune system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research